LU2387457729
Franklin Genomic Advancements Fund
As of 16.06.2026
NAV
€6,47
NAV Change
€-0,05
As of 31.05.2026
Morningstar Overall Rating™
Overall Morningstar Rating
Rating Category: Sector Equity Healthcare
Morningstar Style Box
[products.morningstar-stylebox-title-sr-equity]
| Large | Size | |||
|---|---|---|---|---|
| Medium | ||||
| Small | ||||
| Value | Blend | Growth | ||
| Style | ||||
Historical Morningstar Ratings
| Years | 3 |
| Morningstar Overall Rating™ | |
| Number of Funds In Category | 719 |
| Years | 5 |
| Morningstar Overall Rating™ | |
| Number of Funds In Category |
| Years | 10 |
| Morningstar Overall Rating™ | |
| Number of Funds In Category |
Overview
- Summary of Fund Objective
- Sustainability-related Disclosures
- Investor Profile
- What Are The Key Risks?
Summary of Fund Objective
To seek long-term investment growth, through growth of capital. The Fund mainly invests in equities of companies of any market capitalisation that are related to genomic-based technologies designed to enhance the quality of life, including DNA sequencing, gene editing, and personalised medicine. These investments may be from anywhere in the world, including emerging markets.
Sustainability-related Disclosures
The Fund promotes environmental and social characteristics in accordance with Article 8 of the Sustainable Finance Disclosure Regulation (the “SFDR”).
The Fund’s environmental or social characteristics are assessed both quantitatively and qualitatively, by means of sustainability indicators as well as of the Investment Managers’ proprietary ESG ratings system and its research and engagement process further described in the Website disclosure’s dedicated sections.
As part of its investment decision making process, the Fund’s ESG strategy also uses binding criteria for the selection of underlying assets and applies specific ESG exclusions.
Investor Profile
- Seeking capital appreciation by investing in equity securities.
- Seeking a growth investment in innovative companies related to genomic-based technologies designed to enhance the quality of life.
- Planning to hold their investment for the medium to long term.
What Are The Key Risks?
The value of shares in the Fund and income received from it can go down as well as up and investors may not get back the full amount invested. Performance may also be affected by currency fluctuations. Currency fluctuations may affect the value of overseas investments.
- The Fund invests in equity securities of companies operating within health care related industries. Such securities have historically been subject to significant price movements that may occur suddenly due to market or company-specific factors. As a result, the performance of the Fund can fluctuate over time over relatively short time periods.
- Other significant risks include:
Concentration risk: the risk that arises when a fund invests in relatively few holdings, few sectors or a restricted geographic area. Performance may be more volatile than a fund with a greater number of securities.
Equity risk: prices of equities may be affected by factors such as economic, political, market, and issuer-specific changes. Such changes may adversely affect the value of the equities regardless of company-specific performance.
For a full discussion of all the risks applicable to this Fund, please refer to the “Risk Considerations” section of the current prospectus of Franklin Templeton Investment Funds.
Fund Information
Total Net Assets
$4,30 Million
Fund Inception Date
15.10.2021
Share Class Inception Date
15.10.2021
Base Currency for Fund
USD
Base Currency for Share Class
EUR
Benchmark
MSCI All Country World Index-NR
Asset Class
Equity
Investment Manager
Franklin Advisers, Inc.
Investment Vehicle
Franklin Templeton Investment Funds
Domicile
Luxembourg
EU SFDR Category
Article 8
Minimum Investment
USD 1000
Charges
Initial Charge
3,00%
Ongoing Charges Figure
2,55%
Identifiers
ISIN Code
LU2387457729
Bloomberg Code
FRFGANE LX
SEDOL Code
BMXH4Q5
Fund Number
2339
WKN
A3C4V6
Valor Number
113722568
Fund Managers
Performance
- Discrete Annual Performance
- Cumulative Performance
- Annualised Performance
- Calendar Year Performance
- Risk Measures
Discrete Annual Performance
Discrete Annual Performance
Month End As of 31.05.2026 | Currency | May-25 / May-26 | May-24 / May-25 | May-23 / May-24 | May-22 / May-23 | May-21 / May-22 | May-20 / May-21 | May-19 / May-20 | May-18 / May-19 | May-17 / May-18 | May-16 / May-17 | Performance Inception Date | Fund Overview | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N (acc) EUR (%) | EUR | 31,08 | -22,13 | 1,62 | -12,83 | — | — | — | — | — | — | 15.10.2021 | ||
| MSCI All Country World Index-NR (%) | EUR | 26,73 | 8,68 | 21,34 | 1,34 | 6,39 | 29,05 | 5,62 | 3,40 | 7,74 | 16,35 | — |
Month End As of 31.05.2026 | Currency | May-25 / May-26 | May-24 / May-25 | May-23 / May-24 | May-22 / May-23 | Performance Inception Date | Fund Overview | |
|---|---|---|---|---|---|---|---|---|
| A (acc) EUR-H1 (%) | EUR | 32,07 | -19,14 | 1,84 | -16,11 | 08.02.2022 | ||
| A (acc) SGD-H1 (%) | SGD | 31,17 | -19,65 | 1,95 | -14,16 | 15.10.2021 | ||
| A (acc) USD (%) | USD | 35,36 | -17,86 | 3,99 | -12,59 | 15.10.2021 | ||
| A (Ydis) EUR (%) | EUR | 31,75 | -21,37 | 2,39 | -12,33 | 15.10.2021 | ||
| C (acc) USD (%) | USD | 34,72 | -18,34 | 3,33 | -13,11 | 15.10.2021 | ||
| N (acc) USD (%) | USD | 34,45 | -18,40 | 3,16 | -13,26 | 15.10.2021 | ||
| W (acc) USD (%) | USD | 36,61 | -17,13 | 4,97 | -11,78 | 15.10.2021 |
Cumulative Performance
Cumulative Performance
2021
2021
Selected Month October 2021
2026
2026
Selected Month May 2026
Month End As of 31.05.2026 | Currency | YTD | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | 5 Years | 10 Years | 15 Years | Performance Inception 15.10.2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N (acc) EUR (%) | EUR | -2,73 | 6,48 | 3,22 | -8,17 | 31,08 | 3,72 | — | — | — | -35,90 | |
| MSCI All Country World Index-NR (%) | EUR | 12,87 | 5,71 | 8,80 | 12,70 | 26,73 | 67,12 | 80,18 | 218,31 | 428,92 | 65,08 |
Month End As of 31.05.2026 | Currency | YTD | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | 5 Years | 10 Years | 15 Years | Performance Inception | Performance Inception Date | Fund Overview | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A (acc) EUR-H1 (%) | EUR | -4,23 | 5,62 | 1,32 | -8,55 | 32,07 | 8,76 | — | — | — | -23,00 | 08.02.2022 | ||
| A (acc) SGD-H1 (%) | SGD | -4,57 | 5,57 | 1,17 | -9,01 | 31,17 | 7,45 | — | — | — | -39,40 | 15.10.2021 | ||
| A (acc) USD (%) | USD | -3,20 | 5,88 | 2,15 | -7,50 | 35,36 | 15,62 | — | — | — | -33,40 | 15.10.2021 | ||
| A (Ydis) EUR (%) | EUR | -2,50 | 6,41 | 3,43 | -7,91 | 31,75 | 6,07 | — | — | — | -33,60 | 15.10.2021 | ||
| C (acc) USD (%) | USD | -3,43 | 5,71 | 1,89 | -7,82 | 34,72 | 13,68 | — | — | — | -35,20 | 15.10.2021 | ||
| N (acc) USD (%) | USD | -3,45 | 5,75 | 1,90 | -7,74 | 34,45 | 13,18 | — | — | — | -35,60 | 15.10.2021 | ||
| W (acc) USD (%) | USD | -2,80 | 5,95 | 2,21 | -7,10 | 36,61 | 18,84 | — | — | — | -30,60 | 15.10.2021 |
Annualised Performance
Annualised Performance
Month End As of 31.05.2026 | Currency | 1 Year | 3 Years | 5 Years | 10 Years | 15 Years | Performance Inception 15.10.2021 | |
|---|---|---|---|---|---|---|---|---|
| N (acc) EUR (%) | EUR | 31,08 | 1,22 | — | — | — | -9,17 | |
| MSCI All Country World Index-NR (%) | EUR | 26,73 | 18,67 | 12,50 | 12,28 | 11,74 | 11,45 |
Month End
N (acc) EUR (%)
Currency
EUR
1 Year
31,08
3 Years
1,22
5 Years
—
10 Years
—
15 Years
—
Performance Inception
-9,17
Month End
MSCI All Country World Index-NR (%)
Currency
EUR
1 Year
26,73
3 Years
18,67
5 Years
12,50
10 Years
12,28
15 Years
11,74
Performance Inception
11,45
Month End As of 31.05.2026 | Currency | 1 Year | 3 Years | Performance Inception | Performance Inception Date | Fund Overview | |
|---|---|---|---|---|---|---|---|
| A (acc) EUR-H1 (%) | EUR | 32,07 | 2,84 | -5,89 | 08.02.2022 | ||
| A (acc) SGD-H1 (%) | SGD | 31,17 | 2,42 | -10,27 | 15.10.2021 | ||
| A (acc) USD (%) | USD | 35,36 | 4,96 | -8,41 | 15.10.2021 | ||
| A (Ydis) EUR (%) | EUR | 31,75 | 1,98 | -8,47 | 15.10.2021 | ||
| C (acc) USD (%) | USD | 34,72 | 4,37 | -8,96 | 15.10.2021 | ||
| N (acc) USD (%) | USD | 34,45 | 4,21 | -9,08 | 15.10.2021 | ||
| W (acc) USD (%) | USD | 36,61 | 5,92 | -7,60 | 15.10.2021 |
Month End
A (acc) EUR-H1 (%)
Currency
EUR
1 Year
32,07
3 Years
2,84
Performance Inception
-5,89
Performance Inception Date
08.02.2022
Fund Overview
Month End
A (acc) SGD-H1 (%)
Currency
SGD
1 Year
31,17
3 Years
2,42
Performance Inception
-10,27
Performance Inception Date
15.10.2021
Fund Overview
Month End
A (acc) USD (%)
Currency
USD
1 Year
35,36
3 Years
4,96
Performance Inception
-8,41
Performance Inception Date
15.10.2021
Fund Overview
Month End
A (Ydis) EUR (%)
Currency
EUR
1 Year
31,75
3 Years
1,98
Performance Inception
-8,47
Performance Inception Date
15.10.2021
Fund Overview
Month End
C (acc) USD (%)
Currency
USD
1 Year
34,72
3 Years
4,37
Performance Inception
-8,96
Performance Inception Date
15.10.2021
Fund Overview
Month End
N (acc) USD (%)
Currency
USD
1 Year
34,45
3 Years
4,21
Performance Inception
-9,08
Performance Inception Date
15.10.2021
Fund Overview
Month End
W (acc) USD (%)
Currency
USD
1 Year
36,61
3 Years
5,92
Performance Inception
-7,60
Performance Inception Date
15.10.2021
Fund Overview
Calendar Year Performance
Calendar Year Performance
Month End As of 31.05.2026 | Currency | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | Performance Inception Date | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N (acc) EUR (%) | EUR | -2,73 | 8,93 | -0,98 | -3,78 | -35,07 | — | — | — | — | — | — | 15.10.2021 | |
| MSCI All Country World Index-NR (%) | EUR | 12,87 | 7,86 | 25,33 | 18,06 | -13,01 | 27,54 | 6,65 | 28,93 | -4,85 | 8,89 | 11,09 | — |
Month End As of 31.05.2026 | Currency | YTD | 2025 | 2024 | 2023 | 2022 | Performance Inception Date | Fund Overview | |
|---|---|---|---|---|---|---|---|---|---|
| A (acc) EUR-H1 (%) | EUR | -4,23 | 22,00 | -8,09 | -2,32 | — | 08.02.2022 | ||
| A (acc) SGD-H1 (%) | SGD | -4,57 | 20,95 | -8,22 | -1,72 | -39,38 | 15.10.2021 | ||
| A (acc) USD (%) | USD | -3,20 | 24,41 | -6,43 | 0,00 | -38,44 | 15.10.2021 | ||
| A (Ydis) EUR (%) | EUR | -2,50 | 9,66 | -0,32 | -2,96 | -34,42 | 15.10.2021 | ||
| C (acc) USD (%) | USD | -3,43 | 23,57 | -6,86 | -0,51 | -38,89 | 15.10.2021 | ||
| N (acc) USD (%) | USD | -3,45 | 23,52 | -7,06 | -0,68 | -39,00 | 15.10.2021 | ||
| W (acc) USD (%) | USD | -2,80 | 25,48 | -5,64 | 1,01 | -37,94 | 15.10.2021 |
Risk Measures
Risk Measures
Measured against: MSCI All Country World Index-NR
| Statistics | 1 Year | 3 Years | 5 Years |
|---|---|---|---|
| Beta | 0,46 | 1,01 | — |
| Historical Tracking Error | 19,90 | 15,88 | — |
| Information Ratio | 0,21 | -1,11 | — |
| Standard Deviation (%) | 1 Year | 3 Years | 5 Years |
|---|---|---|---|
| N (acc) EUR | 19,62 | 19,85 | — |
| MSCI All Country World Index-NR | 11,17 | 11,53 | — |
| Sharpe Ratio (%) | 1 Year | 3 Years | 5 Years |
|---|---|---|---|
| N (acc) EUR | 1,49 | -0,08 | — |
Portfolio
Assets
Total Net Assets
$4,30 Million
Positions
Number of Issuers
60
Portfolio Statistics
| Fund | Benchmark | |
|---|---|---|
| Historical 3 Years Sales Growth | 34,43% | — |
| P/E to Growth | 3,50x | — |
| Price to Earnings (12-Month Forward) | 25,35x | — |
| Historical EPS Growth (3 Yr) | -19,38% | 13,32% |
Portfolio Allocations
- Assets
- Geography
- Sector
- Market Capitalisation
Assets
Asset Allocation
Chart
Bar chart with 2 bars.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from 2.3001 to 97.6999.
0%100%25%50%75%125%
End of interactive chart.
| Fund | ||
|---|---|---|
| Equity | 97,70% | |
| Cash & Cash Equivalents | 2,30% |
Geography
Geographic Allocation
Chart
Bar chart with 2 data series.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from 2.3001 to 85.702.
0%100%25%50%75%
End of interactive chart.
| Fund | Benchmark | ||
|---|---|---|---|
| 85,70% | 66,46% | ||
| 8,96% | 14,05% | ||
| 3,04% | 16,07% | ||
| 2,30% | — |
Sector
Sector Allocation
Chart
Bar chart with 7 bars.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from 1.0987 to 55.8618.
0%20%40%60%
End of interactive chart.
| Fund | ||
|---|---|---|
| Biotechnology | 55,86% | |
| Life Sciences Tools & Services | 16,61% | |
| Pharmaceuticals | 12,28% | |
| Health Care Services | 9,51% | |
| Fertilizers & Agricultural Chemicals | 2,35% | |
| Application Software | 1,10% | |
| Cash & Cash Equivalents | 2,30% |
Market Capitalisation
Market Capitalisation Allocation
Chart
Bar chart with 6 bars.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from 3.9335 to 30.3277.
0%10%20%30%40%
End of interactive chart.
| Fund | ||
|---|---|---|
| <2.0 Billion | 3,93% | |
| 2.0-5.0 Billion | 17,77% | |
| 5.0-10.0 Billion | 16,19% | |
| 10.0-25.0 Billion | 30,33% | |
| 25.0-50.0 Billion | 13,73% | |
| >50.0 Billion | 18,05% |
Portfolio Holdings
- Holdings
- Top Ten Holdings
Holdings
Holdings
Security Name
Guardant Health Inc COM USD 0.00001
Weight (%)
8,84
Market Value
380'251
Quantity
2'932
Security Name
Natera Inc COM USD.0001
Weight (%)
6,91
Market Value
297'082
Quantity
1'330
Security Name
Krystal Biotech Inc COM USD 0.000010
Weight (%)
5,92
Market Value
254'641
Quantity
824
Security Name
United Therapeutics Corp COM USD.01
Weight (%)
4,05
Market Value
174'285
Quantity
313
Security Name
Ligand Pharmaceuticals Inc COM B USD.001
Weight (%)
3,81
Market Value
163'996
Quantity
707
Security Name
Bridgebio Pharma Inc COM USD 1
Weight (%)
3,50
Market Value
150'675
Quantity
2'274
Security Name
Adaptive Biotechnologies Corp COM USD0.0001
Weight (%)
3,17
Market Value
136'365
Quantity
9'001
Security Name
Eli Lilly & Co COM NPV
Weight (%)
3,06
Market Value
131'495
Quantity
119
Security Name
Astrazeneca PLC ORD USD 0.25
Weight (%)
2,98
Market Value
127'927
Quantity
689
Security Name
Vertex Pharmaceuticals Inc COM USD.01
Weight (%)
2,78
Market Value
119'493
Quantity
267
Top Ten Holdings
Top Equity Issuers
Chart
Bar chart with 10 bars.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from 2.7792 to 8.8439.
0.0%2.0%4.0%6.0%8.0%10.0%
End of interactive chart.
| Fund | ||
|---|---|---|
| GUARDANT HEALTH INC | 8,84% | |
| NATERA INC | 6,91% | |
| KRYSTAL BIOTECH INC | 5,92% | |
| UNITED THERAPEUTICS CORP | 4,05% | |
| LIGAND PHARMACEUTICALS INC | 3,81% | |
| BRIDGEBIO PHARMA INC | 3,50% | |
| ADAPTIVE BIOTECHNOLOGIES CORP | 3,17% | |
| ELI LILLY & CO | 3,06% | |
| ASTRAZENECA PLC | 2,98% | |
| VERTEX PHARMACEUTICALS INC | 2,78% |
Pricing
Pricing History Chart
Since Inception Time Period
- 1 Month
- 3 Months
- 6 Months
- YTD
- 1 Year
- 3 Years
- Since Inception
June 2026
Jun
2026
| SuSunday | MoMonday | TuTuesday | WeWednesday | ThThursday | FrFriday | SaSaturday |
|---|---|---|---|---|---|---|
June 2026
Jun
2026
| SuSunday | MoMonday | TuTuesday | WeWednesday | ThThursday | FrFriday | SaSaturday |
|---|---|---|---|---|---|---|
Share Prices
NAV
€6,47
NAV Change
€-0,05
NAV Change (%)
-0,77%
Highest / Lowest NAV
| Year | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Highest NAV | €6,94 As on 07.01.2026 | €6,99 As on 26.11.2025 | €6,82 As on 16.07.2024 | €6,78 As on 07.02.2023 | €9,61 As on 03.01.2022 | €10,68 As on 02.11.2021 |
| Lowest NAV | €5,74 As on 27.03.2026 | €4,73 As on 08.04.2025 | €5,85 As on 18.11.2024 | €5,30 As on 30.10.2023 | €6,27 As on 28.12.2022 | €9,39 As on 06.12.2021 |
Historical Data - Daily Fund Prices
1 Month Time Period
- 1 Month
- 3 Months
- 6 Months
- YTD
- 1 Year
- 3 Years
- 5 Years
- Since Inception
June 2026
Jun
2026
| SuSunday | MoMonday | TuTuesday | WeWednesday | ThThursday | FrFriday | SaSaturday |
|---|---|---|---|---|---|---|
June 2026
Jun
2026
| SuSunday | MoMonday | TuTuesday | WeWednesday | ThThursday | FrFriday | SaSaturday |
|---|---|---|---|---|---|---|
NAV
€6,47 (EUR)
Highest NAV
€6,52 (EUR)
Lowest NAV
€5,89 (EUR)
Historical Pricing Results From 18.05.2026 To 16.06.2026
| Date | NAV | NAV Change | NAV Change (%) |
|---|---|---|---|
| 16.06.2026 | €6,47 | €-0,05 | -0,77% |
| 15.06.2026 | €6,52 | €0,06 | 0,93% |
| 12.06.2026 | €6,46 | €-0,03 | -0,46% |
| 11.06.2026 | €6,49 | €0,11 | 1,72% |
| 10.06.2026 | €6,38 | €-0,09 | -1,39% |
| 09.06.2026 | €6,47 | €0,13 | 2,05% |
| 08.06.2026 | €6,34 | €-0,03 | -0,47% |
| 05.06.2026 | €6,37 | €-0,12 | -1,85% |
| 04.06.2026 | €6,49 | €0,18 | 2,85% |
| 03.06.2026 | €6,31 | €0,09 | 1,45% |
| 02.06.2026 | €6,22 | €-0,14 | -2,20% |
| 01.06.2026 | €6,36 | €-0,05 | -0,78% |
| 29.05.2026 | €6,41 | €-0,04 | -0,62% |
| 28.05.2026 | €6,45 | €0,15 | 2,38% |
| 27.05.2026 | €6,30 | €0,06 | 0,96% |
| 26.05.2026 | €6,24 | €0,02 | 0,32% |
| 25.05.2026 | €6,22 | €0,01 | 0,00% |
| 22.05.2026 | €6,22 | €0,01 | 0,16% |
| 21.05.2026 | €6,21 | €0,08 | 1,31% |
| 20.05.2026 | €6,13 | €0,19 | 3,20% |
| 19.05.2026 | €5,94 | €0,05 | 0,85% |
| 18.05.2026 | €5,89 | €-0,06 | -1,01% |
Documents
Product Literature
PDF Format
Fact Sheet - Franklin Genomic Advancements Fund (N (acc) EUR)
Regulatory Documents
PDF Format
Key Information Document - Franklin Genomic Advancements Fund N (acc) EUR
PDF Format
Prospectus (English CH) - Franklin Templeton Investment Funds
PDF Format
Semi Annual Report - Franklin Templeton Investment Funds
PDF Format
Semi Annual Report (abridged) - Franklin Templeton Investment Funds
PDF Format
Annual Report (abridged) - Franklin Templeton Investment Funds
PDF Format
Annual Report - Franklin Templeton Investment Funds
PDF Format
Articles of Incorporation - Franklin Templeton Investment Funds (FTIF)